ABBOTT LABORATORIES (1ABT.MI) Stock Fundamental Analysis

BIT:1ABT • US0028241000

92.7 EUR
+0.49 (+0.53%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

Overall 1ABT gets a fundamental rating of 6 out of 10. We evaluated 1ABT against 63 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making 1ABT a very profitable company, without any liquidiy or solvency issues. 1ABT has a decent growth rate and is not valued too expensively. This makes 1ABT very considerable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • 1ABT had positive earnings in the past year.
  • In the past year 1ABT had a positive cash flow from operations.
  • 1ABT had positive earnings in each of the past 5 years.
  • 1ABT had a positive operating cash flow in each of the past 5 years.
1ABT.MI Yearly Net Income VS EBIT VS OCF VS FCF1ABT.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

  • 1ABT's Return On Assets of 16.60% is amongst the best of the industry. 1ABT outperforms 95.24% of its industry peers.
  • The Return On Equity of 1ABT (27.43%) is better than 96.83% of its industry peers.
  • With a decent Return On Invested Capital value of 9.90%, 1ABT is doing good in the industry, outperforming 79.37% of the companies in the same industry.
  • 1ABT had an Average Return On Invested Capital over the past 3 years of 10.45%. This is in line with the industry average of 9.98%.
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROIC 9.9%
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
1ABT.MI Yearly ROA, ROE, ROIC1ABT.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

  • Looking at the Profit Margin, with a value of 31.88%, 1ABT belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
  • 1ABT's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 18.29%, 1ABT is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 1ABT has grown nicely.
  • 1ABT has a Gross Margin (56.19%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of 1ABT has remained more or less at the same level.
Industry RankSector Rank
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
1ABT.MI Yearly Profit, Operating, Gross Margins1ABT.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • 1ABT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, 1ABT has about the same amount of shares outstanding.
  • The number of shares outstanding for 1ABT has been reduced compared to 5 years ago.
  • 1ABT has a better debt/assets ratio than last year.
1ABT.MI Yearly Shares Outstanding1ABT.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
1ABT.MI Yearly Total Debt VS Total Assets1ABT.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

  • An Altman-Z score of 5.25 indicates that 1ABT is not in any danger for bankruptcy at the moment.
  • 1ABT's Altman-Z score of 5.25 is amongst the best of the industry. 1ABT outperforms 87.30% of its industry peers.
  • The Debt to FCF ratio of 1ABT is 1.87, which is an excellent value as it means it would take 1ABT, only 1.87 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of 1ABT (1.87) is better than 80.95% of its industry peers.
  • 1ABT has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.23, 1ABT is doing good in the industry, outperforming 69.84% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Altman-Z 5.25
ROIC/WACC1.02
WACC9.73%
1ABT.MI Yearly LT Debt VS Equity VS FCF1ABT.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

  • 1ABT has a Current Ratio of 1.70. This is a normal value and indicates that 1ABT is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of 1ABT (1.70) is comparable to the rest of the industry.
  • 1ABT has a Quick Ratio of 1.24. This is a normal value and indicates that 1ABT is financially healthy and should not expect problems in meeting its short term obligations.
  • 1ABT's Quick ratio of 1.24 is in line compared to the rest of the industry. 1ABT outperforms 57.14% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.24
1ABT.MI Yearly Current Assets VS Current Liabilites1ABT.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • 1ABT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.40%, which is quite good.
  • 1ABT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.59% yearly.
  • Looking at the last year, 1ABT shows a small growth in Revenue. The Revenue has grown by 6.37% in the last year.
  • Measured over the past years, 1ABT shows a small growth in Revenue. The Revenue has been growing by 5.63% on average per year.
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%

3.2 Future

  • Based on estimates for the next years, 1ABT will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.68% on average per year.
  • The Revenue is expected to grow by 7.22% on average over the next years.
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.68%
Revenue Next Year6.44%
Revenue Next 2Y7.21%
Revenue Next 3Y7.35%
Revenue Next 5Y7.22%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1ABT.MI Yearly Revenue VS Estimates1ABT.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20B 40B 60B
1ABT.MI Yearly EPS VS Estimates1ABT.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • 1ABT is valuated rather expensively with a Price/Earnings ratio of 22.07.
  • Based on the Price/Earnings ratio, 1ABT is valued a bit cheaper than 76.19% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.67, 1ABT is valued a bit cheaper.
  • A Price/Forward Earnings ratio of 19.20 indicates a rather expensive valuation of 1ABT.
  • 1ABT's Price/Forward Earnings is on the same level as the industry average.
  • 1ABT is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 27.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 22.07
Fwd PE 19.2
1ABT.MI Price Earnings VS Forward Price Earnings1ABT.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ABT is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, 1ABT is valued a bit cheaper than the industry average as 63.49% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 27.67
EV/EBITDA 17.61
1ABT.MI Per share data1ABT.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of 1ABT may justify a higher PE ratio.
PEG (NY)1.93
PEG (5Y)2.91
EPS Next 2Y10.8%
EPS Next 3Y10.58%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.04%, 1ABT has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.97, 1ABT pays a bit more dividend than its industry peers.
  • 1ABT's Dividend Yield is comparable with the S&P500 average which is at 1.80.
Industry RankSector Rank
Dividend Yield 2.04%

5.2 History

  • The dividend of 1ABT is nicely growing with an annual growth rate of 11.40%!
Dividend Growth(5Y)11.4%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 28.93% of the earnings are spent on dividend by 1ABT. This is a low number and sustainable payout ratio.
  • 1ABT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
1ABT.MI Yearly Income VS Free CF VS Dividend1ABT.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
1ABT.MI Dividend Payout.1ABT.MI Dividend Payout, showing the Payout Ratio.1ABT.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ABBOTT LABORATORIES

BIT:1ABT (2/6/2026, 7:00:00 PM)

92.7

+0.49 (+0.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-15
Earnings (Next)01-22
Inst Owners81.33%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap161.19B
Revenue(TTM)43.84B
Net Income(TTM)13.98B
Analysts79.43
Price Target125.12 (34.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.04%
Yearly Dividend1.91
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-0.65%
PT rev (3m)N/A
EPS NQ rev (1m)-0.03%
EPS NQ rev (3m)0.46%
EPS NY rev (1m)0%
EPS NY rev (3m)0.15%
Revenue NQ rev (1m)0.06%
Revenue NQ rev (3m)0.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 22.07
Fwd PE 19.2
P/S 4.37
P/FCF 27.67
P/OCF 20.99
P/B 3.76
P/tB 8.95
EV/EBITDA 17.61
EPS(TTM)4.2
EY4.53%
EPS(NY)4.83
Fwd EY5.21%
FCF(TTM)3.35
FCFY3.61%
OCF(TTM)4.42
OCFY4.76%
SpS21.23
BVpS24.68
TBVpS10.36
PEG (NY)1.93
PEG (5Y)2.91
Graham Number48.29
Profitability
Industry RankSector Rank
ROA 16.6%
ROE 27.43%
ROCE 11.52%
ROIC 9.9%
ROICexc 11.13%
ROICexgc 21.33%
OM 18.29%
PM (TTM) 31.88%
GM 56.19%
FCFM 15.78%
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexgc growth 3Y-24.08%
ROICexgc growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.87
Debt/EBITDA 1.04
Cap/Depr 70.33%
Cap/Sales 5.02%
Interest Coverage 250
Cash Conversion 81.77%
Profit Quality 49.49%
Current Ratio 1.7
Quick Ratio 1.24
Altman-Z 5.25
F-Score7
WACC9.73%
ROIC/WACC1.02
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.68%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
Revenue Next Year6.44%
Revenue Next 2Y7.21%
Revenue Next 3Y7.35%
Revenue Next 5Y7.22%
EBIT growth 1Y15.18%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year27.08%
EBIT Next 3Y15.42%
EBIT Next 5Y13.66%
FCF growth 1Y53.98%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y39.24%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%

ABBOTT LABORATORIES / 1ABT.MI FAQ

What is the fundamental rating for 1ABT stock?

ChartMill assigns a fundamental rating of 6 / 10 to 1ABT.MI.


What is the valuation status for 1ABT stock?

ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (1ABT.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for ABBOTT LABORATORIES?

ABBOTT LABORATORIES (1ABT.MI) has a profitability rating of 7 / 10.


What is the financial health of ABBOTT LABORATORIES (1ABT.MI) stock?

The financial health rating of ABBOTT LABORATORIES (1ABT.MI) is 7 / 10.


What is the earnings growth outlook for ABBOTT LABORATORIES?

The Earnings per Share (EPS) of ABBOTT LABORATORIES (1ABT.MI) is expected to grow by 11.44% in the next year.